Lv772
4500 积分 2024-07-23 加入
Apremilast for Recalcitrant Erythema Nodosum: A Case Series
1个月前
已完结
Apremilast Drug Survival and Tolerability in Real-World Practice
2个月前
已关闭
Assessing Predictive Performance of Fibrosis-4 Index in Settings With Lower Prevalence of Liver Fibrosis
2个月前
已关闭
Is the combination of resmetirom and semaglutide useful for the treatment of metabolic dysfunction‐associated steatohepatitis?
2个月前
已完结
Apremilast, Methotrexate and NB ‐ UVB Phototherapy for Moderate to Severe Psoriasis: Efficacy, Safety, and Immunomodulation in Comparison
2个月前
已完结
Non-alcoholic Fatty Liver Disease in Pregnancy: Clinical Implications, Adverse Outcomes, and Therapeutic Considerations
2个月前
已完结
Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Facts and Hopes
2个月前
已完结
Targeting THR-β for MASLD Treatment: Current Progression and Emerging Prospects
2个月前
已完结
SAT-655 Comparative Analysis of Glucagon Receptor Agonists vs Resmetirom in MASLD and MASH:Network Meta-Analysis of Clinical Trials
3个月前
已完结
Meta‐analysis of clinically available pharmacotherapy of biopsy confirmed metabolic dysfunction associated steatohepatitis ( MASH )
3个月前
已完结
皖公网安备34019202002308
